Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RESPECT: Observational, Prospective, Open-Label, Multi-Center Study Evaluating the Antihypertensive Effect of Treatment With Telmisartan (Alone or in Fixed Combination With HCTZ) in General Practitioner and Specialist Practice in Hypertensive Patients With High and Very High Cardiovascular Risk According to the ESH/ESC Guidelines 2007 Who Are Uncontrolled Under Current Treatment.

Next Previous
Search
Trial Profile

RESPECT: Observational, Prospective, Open-Label, Multi-Center Study Evaluating the Antihypertensive Effect of Treatment With Telmisartan (Alone or in Fixed Combination With HCTZ) in General Practitioner and Specialist Practice in Hypertensive Patients With High and Very High Cardiovascular Risk According to the ESH/ESC Guidelines 2007 Who Are Uncontrolled Under Current Treatment.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms RESPECT
  • Sponsors Boehringer Ingelheim

    • Most Recent Events

    • 01 May 2012 Actual patient number changed from 16 to 2913 as reported by ClinicalTrials.gov.
    • 15 Jan 2010 Actual end date (Dec 2009) and actual number of patients (16) added as reported by ClinicalTrials.gov.
    • 15 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top